Chevy Chase Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.3M | Sell |
37,948
-34
| -0.1% | -$7.44K | 0.02% | 436 |
|
|
2025
Q1 | $8.5M | Sell |
37,982
-318
| -0.8% | -$71.2K | 0.03% | 429 |
|
|
2024
Q4 | $12.5M | Sell |
38,300
-890
| -2% | -$292K | 0.04% | 358 |
|
|
2024
Q3 | $11.8M | Sell |
39,190
-627
| -2% | -$188K | 0.04% | 377 |
|
|
2024
Q2 | $13.1M | Sell |
39,817
-1,158
| -3% | -$381K | 0.04% | 335 |
|
|
2024
Q1 | $16.2M | Sell |
40,975
-356
| -0.9% | -$141K | 0.05% | 301 |
|
|
2023
Q4 | $14.6M | Sell |
41,331
-187
| -0.5% | -$65.8K | 0.05% | 309 |
|
|
2023
Q3 | $15.6M | Sell |
41,518
-1,194
| -3% | -$448K | 0.06% | 279 |
|
|
2023
Q2 | $16.3M | Sell |
42,712
-311
| -0.7% | -$119K | 0.06% | 284 |
|
|
2023
Q1 | $14.9M | Buy |
43,023
+443
| +1% | +$153K | 0.06% | 300 |
|
|
2022
Q4 | $10M | Sell |
42,580
-2,635
| -6% | -$620K | 0.04% | 369 |
|
|
2022
Q3 | $11.1M | Buy |
45,215
+480
| +1% | +$118K | 0.05% | 347 |
|
|
2022
Q2 | $13.5M | Buy |
44,735
+186
| +0.4% | +$56.2K | 0.06% | 307 |
|
|
2022
Q1 | $18.3M | Buy |
44,549
+122
| +0.3% | +$50.1K | 0.06% | 280 |
|
|
2021
Q4 | $20.8M | Sell |
44,427
-995
| -2% | -$467K | 0.07% | 264 |
|
|
2021
Q3 | $19.3M | Sell |
45,422
-1,620
| -3% | -$688K | 0.07% | 261 |
|
|
2021
Q2 | $16.9M | Sell |
47,042
-2,692
| -5% | -$967K | 0.06% | 299 |
|
|
2021
Q1 | $14M | Sell |
49,734
-3,482
| -7% | -$981K | 0.05% | 340 |
|
|
2020
Q4 | $15.1M | Sell |
53,216
-1,538
| -3% | -$436K | 0.05% | 312 |
|
|
2020
Q3 | $15.1M | Sell |
54,754
-4,473
| -8% | -$1.23M | 0.06% | 288 |
|
|
2020
Q2 | $13.5M | Buy |
+59,227
| New | +$13.5M | 0.05% | 312 |
|